An inhibitor of GSK3
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
GSK3 Inhibitor XIII is an aminopyrazole ATP-competitive inhibitor of glycogen synthase kinase 3 (GSK3), with 34% inhibition when used at a concentration of 2.5 µM. It inhibits androgen receptor transactivation in 22Rv1, LNCaP, and LNCaP-SSR cell lines in a dose-dependent manner. It promotes nuclear export of the androgen receptor and decreases translocation to the nucleus in PC3 and PCa prostate cancer cells, respectively. In HEK293 cells expressing the rat Nav1.2 channel, pretreatment with GSK3 inhibitor XIII dose-dependently potentiates peak current densities.
Salinosporamide A (NPI-0052, Marizomib)
¥1300.00 ¥1625.00
2-Iminopiperidine hydrochloride
¥1550.00 ¥1937.00
没有评价数据